sc 53116 has been researched along with nan 190 in 1 studies
Studies (sc 53116) | Trials (sc 53116) | Recent Studies (post-2010) (sc 53116) | Studies (nan 190) | Trials (nan 190) | Recent Studies (post-2010) (nan 190) |
---|---|---|---|---|---|
20 | 0 | 3 | 245 | 0 | 33 |
Protein | Taxonomy | sc 53116 (IC50) | nan 190 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.003 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lambert, HW; Lauder, JM | 1 |
1 other study(ies) available for sc 53116 and nan 190
Article | Year |
---|---|
Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells.
Topics: 4-Aminobenzoic Acid; Animals; Benzamides; Cells, Cultured; Culture Media; Culture Media, Serum-Free; Cyclic AMP; Cysteine; Embryo, Mammalian; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mandible; Mesoderm; Mice; Nialamide; para-Aminobenzoates; Piperazines; Pyrroles; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |